APP and Alzheimer disease: Overall, our results support the hypothesis that cytokine- and Aβ42-stimulated astrocytes could contribute significantly to the total burden of cerebral Aβ in AD, potentially through elevated astrocytic β-secretase processing of APP under neuroinflammatory conditions.